Abstract: a flow pathway subassembly (264, 278) including medicament flow pathway components of a medical device, and a holder (270, 280) configured for holding the components so that a center of gravity of the subassembly is disposed substantially on a central longitudinal axis of the subassembly.
Abstract: An apparatus for delivering therapeutic agent to an eye includes a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy incision to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
Type:
Grant
Filed:
February 11, 2015
Date of Patent:
March 12, 2019
Assignee:
ORBIT BIOMEDICAL LIMITED
Inventors:
Brendan J. Oberkircher, Daniel W. Price, Michael F. Keane, Saeed Sokhanvar, Daniel J. Yasevac, Michel G. Bruehwiler, Leah R. Soffer, Isaac J. Khan, Benjamin L. Ko, Christopher D. Riemann, Nathan D. Grubbs
Abstract: An insufflation pump includes a pump body having a first end and a second end. The pump body includes a syringe mechanism at the first end and an actuation mechanism at the second end. The syringe mechanism includes a plunger. The plunger of the syringe mechanism and the actuation mechanism are linked by a toggle assembly facilitating transfer of power from the actuation mechanism to the syringe mechanism.
Abstract: An automated peritoneal dialysis therapy device includes pump tubing for delivering dialysate to a patient and for removing waste from the patient; a retractable peristaltic pump assembly; and a processor for controlling operations of the automated peritoneal dialysis therapy device. The retractable peristaltic pump assembly includes a retractable peristaltic pump having a pump rotor and a pump base, a heating source, located in the pump base, to heat the dialysate, a first temperature sensor to measure a temperature of the heating source, a second temperature sensor to measure a temperature of the dialysate, a flow sensor to measure an amount of dialysate being pumped, a pressure sensor to measure a pressure of the dialysate being pumped, and a motor to rotate the pump rotor. The processor controls rotational speed, displacement, and a direction of the pump rotor.
Abstract: The present invention discloses a disposable safety self-destruction insulin needle. The invention uses a sleeve-connected linkage structure and realizes an instant reset of the safety sleeve by means of the spring located in the middle axis so as to ensure that the needle tube is not exposed and preferably realizes a tilting and deflection of the self-destruction pressure base due to a plurality of flexible plates unevenly distributed on the inner wall in the needle base so as to finally ensure that the insulin needle cannot be used a second time, in so doing the safety self-destruction operation of the insulin needle is realized.
Abstract: Drug delivery system, injection device, transfer apparatus, vial holder and method of administering and transferring are disclosed. The system may include transfer apparatus and an injection device. The transfer apparatus may have receiving stations for a drug source, such as a vial or vial holder, and for an injection device, and fluid flow pathways for transferring drugs from the source into the injection device. The injection device may include an expandable elastic bladder and an injection cannula that is movable between a plurality of positions.
Type:
Grant
Filed:
June 17, 2014
Date of Patent:
March 27, 2018
Assignee:
Enable Injections, Inc.
Inventors:
Michael D. Hooven, Matthew J. Huddleston, Joetta Renee Palmer, David Stefanchik